Answers are grounded in this paper and cite their sources.
Research reveals a novel hydrogel platform that enhances immunotherapy by reprogramming tumors into responsive niches.
Remote-Controllable Immune-Priming Spot Formation In their Research Article (DOI: 10.1002/adma.202518245), Sung Hoon Kim, Wonseok Choi, Sungmin Han, Young-Min Kim, and co-workers present “Immunoasis,” a spatiotemporally controllable hydrogel platform. By combining local immunoadjuvant delivery with ultrasound-triggered histotripsy, it generates antigen/adjuvant-rich nanocomplexes in situ, reprogramming immune-deserted tumors into immunoresponsive niches and enabling personalized cancer immunotherapy.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: